BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/9/2022 7:25:27 AM | Browse: 462 | Download: 1031
 |
Received |
|
2021-10-05 16:29 |
|
Peer-Review Started |
|
2021-10-05 16:29 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-15 22:09 |
|
Revised |
|
2021-12-05 02:01 |
|
Second Decision |
|
2022-01-15 02:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-01-17 05:28 |
|
Articles in Press |
|
2022-01-17 05:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-01-28 10:03 |
|
Publish the Manuscript Online |
|
2022-02-09 07:25 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jian-Guo Hong, Lun-Jie Yan, Xian Li, Sheng-Yu Yao, Peng Su, Hai-Chao Li, Zi-Niu Ding, Dong-Xu Wang, Zhao-Ru Dong and Tao Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tao Li, MD, Chief Doctor, Department of General Surgery, Qilu Hospital of Shandong University, No. 107 West Wenhua Road, Jinan 250012, Shandong Province, China. litao7709@126.com |
| Key Words |
Metabolic associated fatty liver disease; Prediction model; Calibration; Normal distribution; Nonalcoholic fatty liver disease |
| Core Tip |
The concept of metabolic associated fatty liver disease (MAFLD) was proposed in 2020. Unlike the concept of nonalcoholic fatty liver disease, the exclusion of chronic liver disease was not required in the establishment of diagnosis of MAFLD, but the presence of metabolic associated disease or dysfunction is required. The clinical prediction values and the optimal cutoff values of non-invasive fibrosis scores remain unknown. We read the recent article entitled “Validation of Conventional Non-invasive Fibrosis Scoring Systems in Patients with Metabolic Associated Fatty Liver Disease” with great interest. We would like to share our opinions and criticisms about this valuable work. |
| Publish Date |
2022-02-09 07:25 |
| Citation |
Hong JG, Yan LJ, Li X, Yao SY, Su P, Li HC, Ding ZN, Wang DX, Dong ZR, Li T. Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World J Gastroenterol 2022; 28(6): 689-692 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i6/689.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i6.689 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
